DONNA GRAY: Open Payments
NPI 1437482346 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 41 payments from 16 companies in 2025. Trend: 2023 $1,796 · 2024 $1,484 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $292 |
| Vanda Pharmaceuticals Inc. | 2 | $147 |
| ABBVIE INC. | 10 | $136 |
| PFIZER INC. | 4 | $90 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 3 | $48 |
| Exact Sciences Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $22 |
Products named: EVENITY, FANAPT, REPATHA, NURTEC ODT, VRAYLAR, MOUNJARO, Wegovy, OTEZLA.
Industry payments across MD — which companies pay providers there.
